WDR5 ORCHESTRATES CANCER CELL SELF RENEWAL IN Myc DRIVEN MEDULLOBLASTOMA

被引:0
|
作者
Ghosh, Swati [1 ]
Venkataraman, Sujatha [1 ]
Birks, Diane [1 ]
Foreman, Nicholas [1 ,2 ]
Vibhakar, Rajeev [1 ,2 ]
机构
[1] Univ Colorado, Aurora, CO USA
[2] Children Hosp Colorado, Aurora, CO USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MB-20
引用
收藏
页码:101 / 101
页数:1
相关论文
共 50 条
  • [21] WDR5 is a prognostic biomarker of brain metastasis from non-small cell lung cancer
    Li, Zheng
    Liang, Nan
    Wang, Na
    Jia, Yan
    Tian, Cui
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [22] Interaction of the oncoprotein transcription factor MYC with its chromatin cofactor WDR5 is essential for tumor maintenance
    Thomas, Lance R.
    Adams, Clare M.
    Wang, Jing
    Weissmiller, April M.
    Creighton, Joy
    Lorey, Shelly L.
    Liu, Qi
    Fesik, Stephen W.
    Eischen, Christine M.
    Tansey, William P.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (50) : 25260 - 25268
  • [23] WDR5 REPRESENTS A THERAPEUTICALLY EXPLOITABLE TARGET FOR CANCER STEM CELLS IN GLIOBLASTOMA
    Mitchell, Kelly
    Sprowls, Samuel
    Shakya, Sajina
    Arora, Sonali
    Silver, Daniel
    Goins, Christopher
    Wallace, Lisa
    Roversi, Gustavo
    Schafer, Rachel
    Kay, Kristen
    Miller, Tyler
    Lauko, Adam
    Bassett, John
    Kashyap, Anjali
    Kass, J. D'Amato
    Mulkearns-Hubert, Erin
    Johnson, Sadie
    Alvarado, Joseph
    Rich, Jeremy
    Paddison, Patrick
    Patel, Anoop
    Stauffer, Shaun
    Hubert, Christopher
    Lathia, Justin
    NEURO-ONCOLOGY, 2023, 25
  • [24] The role of PRMT5 in MYC-driven medulloblastoma
    Chaturvedi, Nagendra K.
    Kesherwani, Varun
    Kling, Matthew J.
    Ray, Sutapa
    McGuire, Timothy R.
    Joshi, Shantaram S.
    Sharp, J. Graham
    Coulter, Don W.
    CANCER RESEARCH, 2019, 79 (13)
  • [25] WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in Neuroblastoma
    Sun, Yuting
    Bell, Jessica L.
    Carter, Daniel
    Gherardi, Samuele
    Poulos, Rebecca C.
    Milazzo, Giorgio
    Wong, Jason W. H.
    Al-Awar, Rima
    Tee, Andrew E.
    Liu, Pei Y.
    Liu, Bing
    Atmadibrata, Bernard
    Wong, Matthew
    Trahair, Toby
    Zhao, Quan
    Shohet, Jason M.
    Haupt, Ygal
    Schulte, Johannes H.
    Brown, Peter J.
    Arrowsmith, Cheryl H.
    Vedadi, Masoud
    MacKenzie, Karen L.
    Huettelmaier, Stefan
    Perini, Giovanni
    Marshall, Glenn M.
    Braithwaite, Antony
    Liu, Tao
    CANCER RESEARCH, 2015, 75 (23) : 5143 - 5154
  • [26] Discovery and Structure-Based Design of Inhibitors of the WD Repeat-Containing Protein 5 (WDR5)-MYC Interaction
    Ding, Jian
    Liu, Lulu
    Chiang, Ying-Ling
    Zhao, Mengxi
    Liu, Hejun
    Yang, Fei
    Shen, Lingling
    Lin, Ying
    Deng, Huiwen
    Gao, Jingyan
    Sage, David R.
    West, Laura
    Llamas, Luis A.
    Hao, Xin
    Kawatkar, Sameer
    Li, En
    Jain, Rishi K.
    Tallarico, John A.
    Canham, Stephen M.
    Wang, He
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (12) : 8310 - 8323
  • [27] Targeting the MYC-WDR5 nexus in colorectal cancer
    Foshage, Audra M.
    Thomas, Lance R.
    Stauffer, Shaun R.
    Fesik, Stephen W.
    Tansey, William P.
    CANCER RESEARCH, 2017, 77
  • [28] WDR5 Promotes Proliferation and Correlates with Poor Prognosis in Oesophageal Squamous Cell Carcinoma
    Huang, Di
    Chen, Xue
    Chen, Xuan
    Qu, Yan
    Wang, Yuanyuan
    Yang, Yafei
    Cheng, Yufeng
    ONCOTARGETS AND THERAPY, 2020, 13 : 10525 - 10534
  • [29] Discovery of a dual WDR5 and Ikaros PROTAC degrader as an anti-cancer therapeutic
    Li, Dongxu
    Yu, Xufen
    Kottur, Jithesh
    Gong, Weida
    Zhang, Zhao
    Storey, Aaron J.
    Tsai, Yi-Hsuan
    Uryu, Hidetaka
    Shen, Yudao
    Byrum, Stephanie D.
    Edmondson, Rick D.
    Mackintosh, Samuel G.
    Cai, Ling
    Liu, Zhijie
    Aggarwal, Aneel K.
    Tackett, Alan J.
    Liu, Jing
    Jin, Jian
    Wang, Gang Greg
    ONCOGENE, 2022, 41 (24) : 3328 - 3340
  • [30] Discovery of a dual WDR5 and Ikaros PROTAC degrader as an anti-cancer therapeutic
    Dongxu Li
    Xufen Yu
    Jithesh Kottur
    Weida Gong
    Zhao Zhang
    Aaron J. Storey
    Yi-Hsuan Tsai
    Hidetaka Uryu
    Yudao Shen
    Stephanie D. Byrum
    Rick D. Edmondson
    Samuel G. Mackintosh
    Ling Cai
    Zhijie Liu
    Aneel K. Aggarwal
    Alan J. Tackett
    Jing Liu
    Jian Jin
    Gang Greg Wang
    Oncogene, 2022, 41 : 3328 - 3340